Search

cobas t 511 coagulation analyzer and cobas t 711 coagulation analyzer

Making innovation your routine

cobas t 511 / t 711 coagulation analyzer

For you. For the patient. For tomorrow.

Today's coagulation lab needs to meet​ clinicians' demand for fast and accurate results and cost effective solutions for a large number of routine coagulation parameters.

 

The standalone mid-throughput cobas t 511 coagulation analyzer and the high-throughput cobas t 711 coagulation analyzer aid in the diagnosis of coagulation abnormalities and in monitoring anticoagulant therapy.
 
By delivering high processing power, seamless workflow dynamics, and unique walk away reagent management (W.A.R.M) with smart sample handling,  we answer your need for maximized workflow efficiency and reliable results. Empowering you to support the best outcome for your patients. 

 

cobas t 511 and cobas t 711 coagulation analyzers instrument brochure
Download
cobas t 511 and cobas t 711 coagulation analyzers reagents brochure
Download
processing power

High Processing Power

 

With their high processing power and extensive menu, the cobas t coagulation analyzers enable laboratories to complete their daily testing workload fast, supported by:
 

  • High throughput
  • Large on-board sample capacity
  • Flexible sample loading options and connection to automation
    • Analyzers can be used in random-access or batch modes, and offer true STAT capabilities with dedicated slots for urgent samples   
  • High on-board reagent capacity and up to 2 weeks of on-board stability
  • Increased on-board testing of up to 34,200 tests that allows loading of reagents only once per 2 weeks (for an XL workload Coag Lab)
workflow

Seamless Workflow Dynamics

 

The cobas t coagulation analyzers offer ease of use, continuous operation and maximized productivity, while ensuring operator safety and reliable results to help support better patient care. These benefits are enabled through:
 

  • Continuous loading/unloading of samples, reagents, consumables and waste
  • Flexible sample tube handling supported
    • Open and closed sample tubes on the same rack
    • Multiple tube vendors
  • Sample integrity checks and full traceability of results
  • e-Services available include: e-library access to download key information, Laboratory Information Systems connectivity and remote service support functionalities
reagent management

Unique Walk Away Reagent Management (W.A.R.M.)

 

The cobas t coagulation analyzers are capable of fully automated and scheduled reagent reconstitution - the ultimate enabler of continuous operation. This innovative and convenient concept minimizes user error risks, and ensures the optimized use and high quality of reagents.

 

  • Reagent cassette concept minimizes risk of contamination and evaporation
  • Automated scheduled reagent reconstitution and equilibration to room temperature when needed, without operator intervention
    • Automated import of electronic data via barcode technology
Do you have any questions?
Contact Us
▲ BACK TO TOP ▲ 

The availability of both the cobas t 511 and the cobas t 711 coagulation analyzer gives your lab the freedom to choose the perfect fit for your testing needs. 

Do you have any questions
CONTACT US
Available assays and tests

Available assays and tests

In vitro assay, with increased lupus sensitivity, for the determination of activated partial thromboplastin time (aPTT) in citrated plasma on the indicated cobas t analyzers. The aPTT is used to evaluate the intrinsic coagulation pathway.

In vitro assay for the determination of activated partial thromboplastin time (aPTT) in citrated plasma on the indicated cobas t analyzers. The aPTT is used to evaluate the intrinsic coagulation pathway.

In vitro assay, with reduced lupus sensitivity, for the determination of activated partial thromboplastin time (aPTT) in citrated plasma on the indicated cobas t analyzers. The aPTT is used to evaluate the intrinsic coagulation pathway.

In vitro assay for the quantitative determination of antithrombin activity in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the diagnosis of antithrombin deficiency.

In vitro assay for the quantitative immunological determination of fibrin degradation products (D‑dimer and X‑oligomers) in human citrated plasma on the indicated cobas t analyzers. In conjunction with a non-high clinical probability assessment, a normal D‑dimer result (< 0.5 μg FEUa)/mL) is intended as an aid in the exclusion of deep vein thrombosis (DVT) and pulmonary embolism (PE).

In vitro assay for the quantitative determination of fibrinogen (Clauss method) in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the detection of hypo- and hyperfibrinogenemia, dysfibrinogenemia and afibrinogenemia.

The derived fibrinogen result is intended as an aid in the diagnosis of a fibrinogen deficiency.

In vitro assay for the determination of the Owrens prothrombin time in citrated plasma on the indicated cobas t analyzers. The Owrens prothrombin time is intended as an aid in the management of vitamin K antagonist therapy.

In vitro assay for the determination of prothrombin time and derived fibrinogen in citrated plasma on the indicated cobas t analyzers. The prothrombin time is used for evaluation of the extrinsic coagulation pathway and as an aid in the management of vitamin K antagonist therapy. The derived fibrinogen result is intended as an aid in the diagnosis of a fibrinogen deficiency.

In vitro assay for the determination of Thrombin Time (TT) in human citrated plasma on the indicated cobas t analyzers.

In vitro assay for the quantitative determination of the anti-Xa activity of unfractionated (UFH) and low molecular weight (LMWH) heparins in citrated plasma on the indicated cobas t analyzers. The assay is intended as an aid in the management of anti-Xa Heparin therapy.

In vitro test for the semi-quantitative determination of the lipemia index, hemolysis index and icterus index in citrated plasma on cobas t systems.

▲ BACK TO TOP ▲